AbCellera Names Dr. Sarah Noonberg as Chief Medical Officer
AbCellera, a clinical-stage biotechnology company developing antibody-based medicines in endocrinology, women’s health, immunology, and oncology, has appointed Dr. Sarah Noonberg, MD, PhD, as Chief Medical Officer. Noonberg, a board-certified physician-scientist, brings over two decades of experience leading development programs from discovery to regulatory approvals and commercialization across diverse therapeutic areas, including oncology, neuroscience, rare diseases, gene therapy, and cell therapy…










